Advertisement

Ads Placeholder
Loading...

Sorrento Therapeutics, Inc.

SRNEQ•PNK
Healthcare
Biotechnology
$0.03
$0.001(3.45%)
U.S. Market is Open • 10:06

Sorrento Therapeutics, Inc. (SRNEQ) Stock Overview

Explore Sorrento Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap16.5M
P/E RatioN/A
EPS (TTM)$-1.10
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

SRNEQ Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Sorrento Therapeutics, Inc. (SRNEQ) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 16.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
114.29%
5-Day Change
87.50%
1-Month Change
N/A
3-Month Change
20.00%
6-Month Change
-55.69%
Year-to-Date (YTD) Change
-75.39%
1-Year Change
-85.22%
3-Year Change
-99.54%
5-Year Change
-99.17%
All-Time (Max) Change
-99.92%

Contact Information

https://www.sorrentotherapeutics.com
858 203 4100
4955 Directors Place, San Diego, CA, 92121

Company Facts

9,490 Employees
IPO DateMar 19, 2007
CountryUS

Frequently Asked Questions